- Home
- ONC vs LI Comparison
ONC vs LI Comparison
Compare ONC & LI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONC
- LI
- Stock Information
- Founded
- ONC 2010
- LI 2015
- Country
- ONC Switzerland
- LI China
- Employees
- ONC N/A
- LI N/A
- Industry
- ONC Biotechnology: Pharmaceutical Preparations
- LI Auto Manufacturing
- Sector
- ONC Health Care
- LI Consumer Discretionary
- Exchange
- ONC Nasdaq
- LI Nasdaq
- Market Cap
- ONC 34.8B
- LI 28.5B
- IPO Year
- ONC N/A
- LI 2020
- Fundamental
- Price
- ONC $368.19
- LI $19.77
- Analyst Decision
- ONC Strong Buy
- LI Hold
- Analyst Count
- ONC 12
- LI 5
- Target Price
- ONC $361.00
- LI $23.40
- AVG Volume (30 Days)
- ONC 252.8K
- LI 3.7M
- Earning Date
- ONC 11-06-2025
- LI 11-26-2025
- Dividend Yield
- ONC N/A
- LI N/A
- EPS Growth
- ONC N/A
- LI N/A
- EPS
- ONC 0.29
- LI 1.06
- Revenue
- ONC $4,998,489,124.00
- LI $20,006,186,241.00
- Revenue This Year
- ONC $887.89
- LI N/A
- Revenue Next Year
- ONC $22.45
- LI $31.09
- P/E Ratio
- ONC $1,226.72
- LI $18.63
- Revenue Growth
- ONC 49.15
- LI 7.18
- 52 Week Low
- ONC $170.99
- LI $19.10
- 52 Week High
- ONC $381.50
- LI $33.12
- Technical
- Relative Strength Index (RSI)
- ONC 66.75
- LI 31.34
- Support Level
- ONC $306.60
- LI $19.63
- Resistance Level
- ONC $381.50
- LI $20.57
- Average True Range (ATR)
- ONC 12.71
- LI 0.49
- MACD
- ONC 6.69
- LI 0.05
- Stochastic Oscillator
- ONC 80.96
- LI 22.62
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
About LI Li Auto Inc.
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 500,000 NEVs in 2024, accounting for about 4% of China's passenger new energy vehicle market. Beyond Li One, the company expands its product line, including both BEVs and PHEVs, to target a broader consumer base.